Tacrolimus modified-release + Prograf
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Liver Transplantation
Conditions
Liver Transplantation
Trial Timeline
Mar 1, 2007 → Mar 1, 2009
NCT ID
NCT00459719About Tacrolimus modified-release + Prograf
Tacrolimus modified-release + Prograf is a phase 3 stage product being developed by Astellas Pharma for Liver Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00459719. Target conditions include Liver Transplantation.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00459719 | Phase 3 | Completed |
Competing Products
20 competing products in Liver Transplantation